Journal of Protein Chemistry

, Volume 7, Issue 4, pp 325–339

A reevaluation of the amino acid sequence of human follitropin β-subunit

  • Basudev Shome
  • Albert F. Parlow
  • Wan-Kyng Liu
  • Hyun S. Nahm
  • Ted Wen
  • Darrell N. Ward
Article

DOI: 10.1007/BF01024882

Cite this article as:
Shome, B., Parlow, A.F., Liu, WK. et al. J Protein Chem (1988) 7: 325. doi:10.1007/BF01024882

Abstract

A collaborative study from two laboratories has been undertaken to re-evaluate the human follitropin β-subunit sequence (hFSHβ), since areas of uncertainty remain in the wake of two earlier reports. The first report was by Shome and Parlow (1974). The second, by Saxena and Rathnam (1976), proposed revisions for sequence not definitively placed in the first study, as well as some differences in other placements. We have re-examined the sequence of the hFSHβ with more recent methodology. This has led to revision of certain areas of the sequence and resolution of differences between the two earlier proposals. Specifically, an-Ile-Ser- is established at 21–22, Asp at 41, Arg at 44, Lys at 46, and Glu at 111. These were areas of disagreement in the earlier proposals. A definitive placement of the residues around tryptophan-27 has now been obtained by three laboratories. C-terminal heterogeneity was observed with subunits ending at residue 107, 109, or 111. N-terminal heterogeneity has been observed in all preparations examined to date. A significant population of molecules with a proteolytic nick between residues 38–39 is noted. This is very likely an artifact of the collection and processing. The preparations examined in the present studies showed no evidence of residues 112–118 proposed by Saxena and Rathnam.

Key words

human follitropinβ-subunitamino acid sequence revisionglycoprotein hormonesstructure

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Basudev Shome
    • 1
  • Albert F. Parlow
    • 1
  • Wan-Kyng Liu
    • 2
  • Hyun S. Nahm
    • 2
  • Ted Wen
    • 2
  • Darrell N. Ward
    • 2
  1. 1.UCLA School of Medicine, Department of Obstetrics and GynecologyHarbor General HospitalTorrance
  2. 2.Department of Biochemistry and Molecular BiologyThe University of Texas System Cancer Center M. D. Anderson Hospital and Tumor InstituteHouston